Interaction of spironolactone and digoxin in dogs.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001682:Biological Availability; D001794:Blood Pressure / Q000187:drug effects; D004077:Digoxin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D004285:Dogs; D004347:Drug Interactions; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008566:Membranes / Q000201:enzymology; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology / Q000648:ultrastructure; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013148:Spironolactone / Q000494:pharmacology*
D013148:Spironolactone; D004077:Digoxin; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium